LUMOS DIAGNOSTICS HOLDINGS LIMITED (LDX)

No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
DOUG WARD Director
Transaction date
Purchase
Price
399.17
Quantity 21,805
Value A$3,304,438
Sam Lanyon Director
Transaction date
Planned purchase
Price
198.54
Quantity 14,341
Value A$1,738,509
Catherine Robson Director
Transaction date
Planned purchase
Price
125.96
Quantity 54,961
Value A$1,959,517
Bronwyn Le Grice Director
Transaction date
Planned purchase
Price
0.07
Quantity 71,428
Value A$5,000
Sam Lanyon Director
Transaction date
Purchase
Price
0.01
Quantity 2,197,132
Value A$26,426
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2023-10-24 2023-10-18 B Purchase DOUG WARD Director
21,805
399.17
A$3,304,438
21,805 399.17 A$3,304,438
2023-08-03 2023-08-03 PP Planned purchase Sam Lanyon Director
14,341
198.54
A$1,738,509
14,341 198.54 A$1,738,509
2023-08-03 2023-08-03 PP Planned purchase Catherine Robson Director
54,961
125.96
A$1,959,517
54,961 125.96 A$1,959,517
2023-08-03 2023-08-03 PP Planned purchase Bronwyn Le Grice Director
71,428
0.07
A$5,000
71,428 0.07 A$5,000
2022-12-02 2022-11-30 B Purchase Sam Lanyon Director
2,197,132
0.01
A$26,426
2,197,132 0.01 A$26,426
Explore more

More insider trading research around LUMOS DIAGNOSTICS HOLDINGS LIMITED